Secondary Stock Offerings
By The Online Investor Staff, updated Wed., May. 27, 10:41 AM
| This Slide: #3 of 25 |
Slide #3. TransMedics Group, Inc. — Secondary Offering
Company:
TransMedics Group, Inc. (NASDAQ:TMDX)
Date announced:
5/26/2020
Secondary Offering Details:
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today the commencement of a proposed public offering of $60 million of its shares of common stock. All of the shares will be offered by TransMedics. TransMedics also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount of up to 15 percent of the number of shares sold in the offering.
TransMedics is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. Co. developed the Organ Care System (“OCS”) to replace a decades-old standard of care. The OCS represents a paradigm shift that transforms organ preservation for transplantation from a static state to a dynamic environment that enables new capabilities, including organ optimization and assessment. Co.'s OCS technology replicates many aspects of the organ's natural living and functioning environment outside of the human body.
TMDX SEC Filing Email Alerts Service
Open the TMDX Page at The Online Investor »
|
|||||||||||||||||||||
Open the TMDX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.60 out of 4) 69th percentile
(ranked higher than approx. 69% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
